Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring viral load in the clinical setting

R Harrigan1

  • 1Antiviral Therapeutic Research Unit, Wellcome Research Laboratories, Beckenham, Kent, England.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association
|January 1, 1995
PubMed
Summary

Quantitative viral nucleic acid measurement offers a practical alternative to traditional clinical trials for assessing antiretroviral therapy efficacy. Combination therapies, particularly zidovudine/lamivudine, demonstrate superior viral load reduction compared to monotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.

HIV medicine·2017
Same author

Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings.

The Journal of antimicrobial chemotherapy·2010
Same author

A compromise strategy for patients with multiple drug failure.

AIDS (London, England)·2002
Same author

Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up.

Antiviral therapy·2001

Area of Science:

  • Virology
  • Clinical Pharmacology
  • Infectious Diseases

Background:

  • Traditional clinical endpoint studies for antiretroviral treatments face ethical and practical challenges.
  • Increasing availability of antiretroviral options and early treatment initiation necessitate alternative efficacy assessment methods.
  • Quantitative viral nucleic acid assays are emerging as valuable tools for predicting promising drug regimens.

Purpose of the Study:

  • To evaluate the efficacy of different antiretroviral regimens using quantitative viral nucleic acid measurements.
  • To compare the effectiveness of zidovudine (AZT) monotherapy with various combination therapies.
  • To assess the correlation between viral load reduction and CD4 cell count increases.

Main Methods:

  • Utilized quantitative measures of viral nucleic acids (HIV-1 RNA) in serum.

Related Experiment Videos

  • Conducted clinical trials comparing zidovudine (AZT) monotherapy against combinations: AZT/didanosine (ddI), AZT/zalcitabine (ddC), and AZT/lamivudine (3TC).
  • Monitored changes in HIV-1 RNA levels and CD4 cell counts in antiretroviral-naive patients.

    • Main Results:

    • AZT monotherapy resulted in approximately 50% decrease in HIV-1 RNA levels.
    • Combinations AZT/ddI and AZT/ddC showed significantly greater reductions (80-90%).
    • The AZT/3TC combination demonstrated superior and sustained viral load reduction (>1.8 log RNA copies/ml vs. 0.7 log RNA copies/ml at 4 weeks) compared to AZT monotherapy, with corresponding CD4 cell count increases.

    Conclusions:

    • Quantitative viral load assessment is a practical and promising method for monitoring antiretroviral drug action.
    • Combination antiretroviral therapies, especially AZT/3TC, achieve greater and more sustained viral load reduction than monotherapy.
    • Viral load reduction correlates with increases in CD4 cell counts, indicating treatment effectiveness.